News Sentiment

LLY sentiment intelligence

Eli Lilly and Company news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors Options RSS feed
Weighted score 59 Balanced news tone 22 relevant articles
Exchange NYSE United States
Sector Healthcare Market context
Industry Drug Manufacturers - General Read-through group
Latest close 1098.57 Week of 19 Jun 2026
Weighted tone 59/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

86/100 classification confidence.

Company focus 22

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-3.0% over one week, +3.2% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Positive

Is Eli Lilly and Company (LLY) among the Best Longevity and Anti-Aging Stocks to Buy?

Market Reaction

Balanced read

71/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 86/100 classification
One-week reaction -3.0% Price reacting lower
Trend fit Trend inactive 3.2% over four weeks
Fair value 38.2% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 9
Negative 1

Relevance

Why the article matched

Direct first
Direct company coverage 22
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 7
Insider Monkey 2
simplywall.st 2
AD HOC NEWS 2
Trefis 2
Simply Wall Street 1
Quiver Quantitative 1
Investing.com 1

Event Lens

What the news is about

Classified themes
Market update 16
Analyst action 2
Regulatory and legal 2
Capital return 1
Earnings 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-22 of 22
Insider Monkey Direct company coverage

Is Eli Lilly and Company (LLY) among the Best Longevity and Anti-Aging Stocks to Buy?

Eli Lilly and Company (LLY) is considered one of the top longevity and anti-aging stocks, with a short percentage of shares outstanding at 1.10%. The company recently acquired 4E Therapeutics, a neuroscience firm developing treatments for chronic pain, and reported positive Phase

Tone
Positive 72/100
Event
Market update
Published
22 Jun 2026 13:14
Source
Insider Monkey
Simply Wall Street Direct company coverage

Charles River Laboratories International (CRL) Stock Could Be 41% Undervalued After Lilly Tie Up And Upgrade

Charles River Laboratories International (CRL) is gaining attention due to a Morgan Stanley upgrade and a new collaboration with Eli Lilly's AI drug discovery platform, TuneLab. While some narratives suggest the stock is 41% undervalued with a fair value of $313.61, the Simply Wa

Tone
Positive 65/100
Event
Analyst action
Published
21 Jun 2026 08:23
Source
Simply Wall Street
Investing.com Direct company coverage

Cathie Wood’s ARK sells Roku stock, buys Tesla and Snowflake

Cathie Wood's ARK sold a significant portion of its Roku Inc (NASDAQ:ROKU) shares while increasing its holdings in Tesla Inc (NASDAQ:TSLA) and Snowflake Inc (NYSE:SNOW). The daily trades for Thursday, June 18th, 2026, also included purchases in Eli Lilly and Co (NYSE:LLY), Genera

Tone
Positive 62/100
Event
Market update
Published
19 Jun 2026 23:42
Source
Investing.com
Insider Monkey Direct company coverage

Eli Lilly and Company (LLY) is one of the Best Growth Stocks to Buy According Ray Dalio

Eli Lilly and Company (LLY) is highlighted as a top growth stock by Ray Dalio's Bridgewater Associates, following the FDA's approval of a new dosing regimen for its atopic dermatitis drug, EBGLYSS, on June 10, 2026. This updated regimen allows for less frequent injections, improv

Tone
Positive 71/100
Event
Regulatory and legal
Published
18 Jun 2026 23:08
Source
Insider Monkey